Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Creative Medical Technology Holdings (CELZ) FCF Margin (2017 - 2025)

Historic FCF Margin for Creative Medical Technology Holdings (CELZ) over the last 9 years, with Q1 2025 value amounting to 53051.17%.

  • Creative Medical Technology Holdings' FCF Margin changed N/A to 53051.17% in Q1 2025 from the same period last year, while for Sep 2025 it was 97807.12%, marking a year-over-year decrease of 501094900.0%. This contributed to the annual value of 48193.56% for FY2024, which is 410051600.0% up from last year.
  • Latest data reveals that Creative Medical Technology Holdings reported FCF Margin of 53051.17% as of Q1 2025.
  • Creative Medical Technology Holdings' 5-year FCF Margin high stood at 1587.82% for Q3 2022, and its period low was 64984.53% during Q4 2024.
  • Moreover, its 5-year median value for FCF Margin was 18366.3% (2024), whereas its average is 23687.42%.
  • In the last 5 years, Creative Medical Technology Holdings' FCF Margin soared by 23200700bps in 2022 and then tumbled by -438583900bps in 2023.
  • Over the past 5 years, Creative Medical Technology Holdings' FCF Margin (Quarter) stood at 1714.05% in 2021, then plummeted by -1026bps to 19307.71% in 2022, then crashed by -227bps to 63166.1% in 2023, then dropped by -3bps to 64984.53% in 2024, then grew by 18bps to 53051.17% in 2025.
  • Its last three reported values are 53051.17% in Q1 2025, 64984.53% for Q4 2024, and 18366.3% during Q2 2024.